Researchers at Monash University have revealed the significant impact that severe COVID-19 infections during pregnancy may have on the health of the unborn child in a ground-breaking study. Under the direction of Dr. Hill, the team has discovered a connection between maternal COVID-19 and alterations in newborns’ DNA methylation patterns, which may result in neurodevelopment impairments.

The study focused on a cohort of pregnant women who sustained severe COVID-19 infections and their babies. Utilizing new genomic and developmental screening technologies, the researchers evaluated how the viral infection changed the epigenetic markers in the infants’ DNA particularly DNA methylation, a process crucial for controlling gene expression during development.

DNA methylation is important for the development of the early brain, according to Dr. Hill; Changes in this mechanism can cause long-term effects on cognitive and motor performance by upsetting neuronal circuits.

The finding suggests that, at delivery, the inflammatory marker IL-6 was more prevalent in women who had severe COVID-19 infections during pregnancy, at 12 months of age; newborns exposed to COVID-19 had impaired neurodevelopment. Infant communication and problem-solving scores were negatively linked with higher maternal IL-6 levels at delivery.

In exposed newborns, there were differences in DNA methylation patterns, especially in genes related to brain development. These babies were more likely to show delayed milestones in areas including speech, motor skills, and social interaction, according to preliminary findings.

According to Dr. Hill, these methylation patterns may be used as a biological signature to identify newborns that are at risk of neurodevelopment problems. But further study is required to validate this and turn it into a useful diagnostic tool.

The team from Monash University intends to carry out further studies to evaluate the impacted newborns’ long-term cognitive, emotional, and social effects in order to broaden this research. This is the reason researchers have spent the last four years tracking these families. To better detect and describe neurodevelopment problems, the team is now performing essential four-year follow-up visits.

The study emphasizes how vital it is to protect pregnant women’s health, especially in light of international health emergencies like COVID-19. Researchers from Monash University are opening the door to better healthcare practices for both mothers and babies by determining the epigenetic and developmental effects of severe illnesses.

References
  1. Hill, R.A., Gibbons, A., Suwakulsiri, W. et al. Investigating the impact of severe maternal SARS-CoV-2 infection on infant DNA methylation and neurodevelopment. Mol Psychiatry (2024). https://doi.org/10.1038/s41380-024-02808-x
  2. Hill, R.A., Gibbons, A., Han U., et al, Maternal SARS-CoV-2 exposure alters infant DNA methylation, Brain, Behavior & Immunity – Health, Volume 27, February 2023, 100572. https://doi.org/10.1016/j.bbih.2022.100572
  3. Anna Suleri, Tonya White, Elisabet Blok, The Association Between Prenatal Infection and Adolescent Behavior: Investigating Multiple Prenatal, Perinatal, and Childhood Second Hits, J Am Acad Child Adolesc Psychiatry 2023;62(12):1340-1350

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Phase II trials of the first-ever blood-stage malaria vaccine in children from Burkina Faso showed encouraging results

One of the most deadly infectious illnesses in the world, malaria has long been a problem for public health. Malaria, which is mostly found in sub-Saharan Africa, is a disease

Zepbound Cleared by FDA for Moderate to Severe Sleep Apnea in Obese Populations

Zepbound (tirzepatide), the first drug approved by the U.S. Food and Drug Administration (FDA), is used to treat moderate to severe obstructive sleep apnoea (OSA) in obese people. To be

Artificial Intelligence in Medicine: Revolutionizing Healthcare

Healthcare is one of the many areas that artificial intelligence (AI) is quickly changing. AI has advanced medicine significantly over the last ten years, providing creative ways to enhance patient